Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial). uri icon

Overview

publication date

  • January 2, 2018

Research

keywords

  • Anticoagulants
  • Benzamides
  • Enoxaparin
  • Factor Xa Inhibitors
  • Fibrinolytic Agents
  • Inpatients
  • Patient Readmission
  • Pyridines
  • Venous Thromboembolism

Identity

Scopus Document Identifier

  • 85047911296

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.117.031187

PubMed ID

  • 29279341

Additional Document Info

volume

  • 137

issue

  • 1